Biopharma

9 Ways Payers May be Impacted by Vertical Integration

The transformation of the healthcare delivery model and the reinvention of the PBMs will have implications for payers – what are the threats and opportunities? The below post is an excerpt from our white paper Beyond the PBM: A New Order for Healthcare Delivery.    Vertical integration giving PBMs a bigger role in the healthcare value […]

IDNs’ Continued Displacement of Traditional Insurers

Partners, Harvard Pilgrim Negotiations Underscore Growing Trend Amid continued merger mania in the U.S. healthcare industry, the news that integrated delivery titan Partners HealthCare is exploring a merger with innovative New England insurer Harvard Pilgrim Health Care stands out. The deal would not only add to a collection of tie-ups that are blurring the industry’s […]

Novo Nordisk’s Ozempic: Launch was late but sales forecasts climbing

This article is part of an ongoing blog series profiling the12 new, game-changing drugs predicted to achieve blockbuster status by 2022 in the 2018 edition of Drugs to Watch, the annual industry forecast and analysis from Clarivate Analytics. Read the full Drugs to Watch report here or follow the series for the latest updates. Drugs […]

Algeria, Morocco and Tunisia changing their regulatory landscape?

Algeria, Morocco and Tunisia have fantastic potential for development in the pharmaceutical sector but weaknesses in some aspects of the pharma regulatory system create barriers to market access. Conscious of this, regulatory authorities in the region say they are determined to improve regulatory processes to allow faster access to market for essential and innovative medicines. […]

GSK’s Shingrix set to become the market leading shingles vaccine

This article is part of an ongoing blog series profiling the twelve new, game-changing drugs predicted to achieve blockbuster status by 2022 in the 2018 edition of Drugs to Watch, the annual industry forecast and analysis from Clarivate Analytics. Read the full Drugs to Watch report here or follow the series for latest updates. The […]

The opioid crisis: a 21st century pain

This article is a Clarivate Analytics Market Insight report, an ongoing series featuring expert reviews of hot topics in the pharma/biotech field, with analysis and discussion on the factors currently affecting the industry. Data leveraged for this analysis was gathered from Clarivate Analytics Cortellis.   The pain market Due to the significant healthcare and economic […]

With Cigna–Express Scripts, last PBM domino falls

The last pharmacy benefit management giant waiting for a potential suitor is off the board now that Cigna and Express Scripts plan a $67 billion merger. For Express Scripts, the last of the large independent PBMs, a merger with Cigna makes sense. Express Scripts was in a bind. After an ugly divorce, Express Scripts lost […]

PolyPEPI-1018: A hopeful advance in the fight against cancer – and a milestone for us

Meet PolyPEPI-1018, a cancer vaccine being developed by Treos Bio Ltd. for the treatment of metastatic colorectal cancer. PolyPEPI-1018 contains six synthetic polypeptides that are precisely selected to induce immune cell responses against 12 epitopes from seven cancer testis antigens (CTAs) most frequently expressed in colorectal cancers. These polypeptides are optimized with the PEPI biomarker […]

Acorda and Sunovion: Coming to the “Rescue” in Parkinson’s Disease?

A core unmet need in Parkinson’s disease (PD) is a new way to address “off” time, a term that refers to the return of motor symptoms when a dose of levodopa (the standard of care in PD) wears off prematurely or doesn’t provide full therapeutic benefit. DRG’s epidemiologists estimate that as many as 40% of […]